Furthermore, the results of an in vivo xenograft mouse model showed that folic acid significantly reduced tumor volume and inhibited ESCC growth, especially in the RPS15-overexpressing xenograft group. Here, RPS15 is linked to esophageal squamous cell carcinoma.